Net Cash Provided by (Used in) Operating Activities |
-68.6K |
USD |
+48.7% |
Sep 30, 2023 |
Q3 2023 |
Net Cash Provided by (Used in) Financing Activities |
450K |
USD |
+181% |
Sep 30, 2023 |
Q3 2023 |
Net Cash Provided by (Used in) Investing Activities |
-475K |
USD |
|
Sep 30, 2023 |
Q3 2023 |
Common Stock, Shares Authorized |
400M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
8.66M |
shares |
+105% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
58 |
USD |
-100% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
1.97M |
USD |
+14.7% |
Jun 30, 2023 |
Q2 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2022 |
Q4 2022 |
Depreciation |
0 |
USD |
-100% |
Jun 30, 2022 |
Q2 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
10.1M |
USD |
+7.51% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Jun 30, 2023 |
Q2 2023 |
Interest Expense |
8.44K |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |